Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
about
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Subtype C ALVAC-HIV and bivale ...... can adults: a phase 1/2 trial.
@en
Subtype C ALVAC-HIV and bivale ...... can adults: a phase 1/2 trial.
@nl
type
label
Subtype C ALVAC-HIV and bivale ...... can adults: a phase 1/2 trial.
@en
Subtype C ALVAC-HIV and bivale ...... can adults: a phase 1/2 trial.
@nl
altLabel
Subtype C ALVAC-HIV and bivale ...... ican adults: a phase 1/2 trial
@en
prefLabel
Subtype C ALVAC-HIV and bivale ...... can adults: a phase 1/2 trial.
@en
Subtype C ALVAC-HIV and bivale ...... can adults: a phase 1/2 trial.
@nl
P2093
P2860
P50
P921
P1433
P1476
Subtype C ALVAC-HIV and bivale ...... can adults: a phase 1/2 trial.
@en
P2093
Brodie Daniels
Carlos A DiazGranados
Carter Bentley
Chenchen Yu
Craig Innes
Daryl E Morris
Fatima Laher
Georgia D Tomaras
Glenda E Gray
HVTN 100 Protocol Team
P2860
P304
P356
10.1016/S2352-3018(18)30071-7
P407
P50
P577
2018-06-08T00:00:00Z